var szzbAffiches=[["08369","finalpage/2017-07-05/1203683727.PDF","立基工程控股：截至二零一七年六月三十日止月份之股份发行人的证券变动月报表","PDF","509","2017-07-05","2017-07-05 15:52"],["08446","finalpage/2017-07-05/1203683597.PDF","ITP Holdings：截至二零一七年六月三十日止股份发行人的证券变动月报表","PDF","572","2017-07-05","2017-07-05 15:12"],["08439","finalpage/2017-07-05/1203683577.PDF","新百利融资：截至二零一七年六月三十日止股份发行人的证券变动月报表","PDF","631","2017-07-05","2017-07-05 14:56"],["08155","finalpage/2017-07-05/1203683578.PDF","南华资产控股：截至二零一七年六月三十日止月份之股份发行人的证券变动月报表","PDF","501","2017-07-05","2017-07-05 14:56"],["08051","finalpage/2017-07-05/1203683573.PDF","讯智海：截至2017年6月30日止之股份发行人的证券变动月报表","PDF","259","2017-07-05","2017-07-05 14:52"],["08131","finalpage/2017-07-05/1203683571.PDF","辰罡科技：股份发行人的证券变动月报表截至2017年6月30日","PDF","172","2017-07-05","2017-07-05 14:44"],["08200","finalpage/2017-07-05/1203683484.PDF","修身堂：截至二零一七年六月三十日止股份发行人的证券变动月报表","PDF","376","2017-07-05","2017-07-05 12:51"],["08276","finalpage/2017-07-05/1203683464.PDF","华章科技：澄清公告","PDF","379","2017-07-05","2017-07-05 12:07"],["08158","finalpage/2017-07-05/1203683458.PDF","中国再生医学：生物工程角膜「艾欣瞳」被列为国家卫生计生委防盲科研计划临床应用多中心研究课题","PDF","1597","2017-07-05","2017-07-05 12:04"],["08113","finalpage/2017-07-05/1203683418.PDF","扬宇科技：截至二零一七年六月三十日止之股份发行人的证券变动月报表","PDF","501","2017-07-05","2017-07-05 10:26"],["08237","finalpage/2017-07-05/1203683398.PDF","华星控股：截至二零一七年六月三十日止股份发行人的证券变动月报表","PDF","190","2017-07-05","2017-07-05 09:10"],["08101","finalpage/2017-07-05/1203683397.PDF","汇盈控股：截至二零一七年六月三十日止股份发行人的证券变动月报表","PDF","195","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683390.PDF","盛业资本：公司资料报表","PDF","297","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683389.PDF","盛业资本：提名委员会 - 职权范围","PDF","115","2017-07-05","2017-07-05 09:04"],["08160","finalpage/2017-07-05/1203683392.PDF","^浚国际：截至二零一七年六月三十日止股份发行人的证券变动月报表","PDF","513","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683388.PDF","盛业资本：薪酬委员会 - 职权范围","PDF","127","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683387.PDF","盛业资本：审核委员会 - 职权范围","PDF","177","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683386.PDF","盛业资本：董事名单与其角色和职能","PDF","42","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683384.PDF","盛业资本：经修订及重订之组织章程大纲及章程细则","PDF","587","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683383.PDF","盛业资本：发售价及配发结果公布","PDF","224","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683382.PDF","盛业资本：发售价及配发结果公布","PDF","86","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683381.PDF","盛业资本：发售价及配发结果公布","PDF","68","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683380.PDF","盛业资本：发售价及配发结果公布","PDF","70","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683379.PDF","盛业资本：发售价及配发结果公布","PDF","271","2017-07-05","2017-07-05 09:04"],["08469","finalpage/2017-07-05/1203683378.PDF","盛业资本：发售价及配发结果公布","PDF","432","2017-07-05","2017-07-05 09:04"],["08159","finalpage/2017-07-05/1203683372.PDF","辉煌科技：持续关连交易业务合作及服务协议","PDF","185","2017-07-05","2017-07-05 09:04"]];
